BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 213013)

  • 1. [Action of a combination of norsulfazole and polymyxin M on the fatty acid makeup of Pr. mirabilis].
    Lukach IG; Vasiurenko ZP
    Antibiotiki; 1978 Oct; 23(10):934-40. PubMed ID: 213013
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of norsulfazole on the fatty acid makeup of enterobacteria].
    Vasiurenko ZP; Lukach IG
    Mikrobiol Zh (1978); 1979; 41(4):367-72. PubMed ID: 393968
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of polymyxins on the lipopolysaccharide-defective mutants of Proteus mirabilis.
    Kaca W; Radziejewska-Lebrecht J; Bhat UR
    Microbios; 1990; 61(246):23-32. PubMed ID: 2156134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of nutrient depletion on the drug resistance of a polymyxin-sensitive Proteus mirabilis [proceedings].
    Dujaili AA; Klemperer RM; Brown MR
    J Pharm Pharmacol; 1977 Dec; 29 Suppl():8P. PubMed ID: 22714
    [No Abstract]   [Full Text] [Related]  

  • 5. Combinations of antimicrobial agents: II. The in vitro sensitivity of 52 strains of proteus species to sulphafurazole, polymyxins and combinations of sulphafurazole and polymyxins.
    Kuipers JS
    Arch Chir Neerl; 1976; 28(1):33-41. PubMed ID: 180905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of polymyxin B on antibiotic-resistant Proteus mirabilis.
    Sud IJ; Feingold DS
    Antimicrob Agents Chemother; 1972 May; 1(5):417-21. PubMed ID: 4363786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructural changes produced in Proteus vulgaris by a synergistic combination of colistin and sulphadiazine.
    Handley PS; Quesnel LB; Sturgiss MM
    Microbios; 1974 May; 10(40):211-23. PubMed ID: 4369409
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanism of polymyxin B resistance in Proteus mirabilis.
    Sud IJ; Feingold DS
    J Bacteriol; 1970 Oct; 104(1):289-94. PubMed ID: 4319722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergism of polymyxin and sulfonamides in L-forms of Staphylococcus aureus and Proteus mirabilis.
    Montgomerie JZ; Kalmanson GM; Guze LB
    Antimicrob Agents Chemother; 1973 Apr; 3(4):523-5. PubMed ID: 4364179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymyxin B-penicillin antagonism in Proteus mirabilis.
    Sud IJ; Feingold DS
    Antimicrob Agents Chemother; 1978 Dec; 14(6):916-8. PubMed ID: 217303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The in vitro effects of cephalothin, gentamicin and their combination against Proteus mirabilis and Enterococci].
    Lode H; Naumann P
    Adv Clin Pharmacol; 1974; 8():46-50. PubMed ID: 4619756
    [No Abstract]   [Full Text] [Related]  

  • 12. Transmissible drug resistance in Proteus mirabilis.
    Rao RS; Sundaraj T; Subramanian S
    Indian J Pathol Microbiol; 1984 Jan; 27(1):37-42. PubMed ID: 6392091
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies of antibiotic resistance of rough and smooth Proteus mirabilis strains and influence of polymyxin E on their lipopolysaccharide composition.
    Kaca W; Ujazda E
    Acta Microbiol Pol; 1996; 45(2):161-8. PubMed ID: 8997693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of polymyxin M on transduction of drug resistance factors in Staphylococcus aureus].
    Koniaev GA; Pavlov EP
    Antibiotiki; 1972 May; 17(5):453-6. PubMed ID: 4338057
    [No Abstract]   [Full Text] [Related]  

  • 15. The occurrence of the trehalose fermenting, tetracycline and polymyxin resistant phenotype among the Enterobacteriaceae.
    Siboni K
    Acta Pathol Microbiol Scand B; 1980 Aug; 88(4):185-8. PubMed ID: 6251697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipids of antibiotic-resistant and -susceptible members of the Enterobacteriaceae.
    Suling WJ; O'Leary WM
    Can J Microbiol; 1977 Aug; 23(8):1045-51. PubMed ID: 329961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synergism of colistin and sulfonamide in proteus species (author's transl)].
    Kunz HH
    Arzneimittelforschung; 1975 Nov; 25(11):1692-5. PubMed ID: 1106440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief exposure of bacteria to topical antibiotics.
    Scherr DD; Dodd TA
    Surg Gynecol Obstet; 1973 Jul; 137(1):87-90. PubMed ID: 4351660
    [No Abstract]   [Full Text] [Related]  

  • 19. The molecular nature of a drug resistance factor in Proteus mirabilis.
    Van Rensburg AJ
    S Afr Med J; 1972 Feb; 46(9):200-2. PubMed ID: 4552782
    [No Abstract]   [Full Text] [Related]  

  • 20. [Taxonomic significance of the lipopolysaccharide fatty acid composition of bacteria in the genus Proteus].
    Cherniavskaia EN; Vasiurenko ZP
    Izv Akad Nauk SSSR Biol; 1984; (5):784-90. PubMed ID: 6389642
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.